• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BECTON DICKINSON, S.A. BD PHASEAL¿ OPTIMA INJECTOR N40-O; INTRAVASCULAR ADMINISTRATION SET

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BECTON DICKINSON, S.A. BD PHASEAL¿ OPTIMA INJECTOR N40-O; INTRAVASCULAR ADMINISTRATION SET Back to Search Results
Catalog Number 515057
Medical Device Problem Codes Fluid/Blood Leak (1250); Defective Component (2292)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 08/09/2023
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
D4: medical device expiration date: unknown.H4: device manufacture date: unknown.H3: a device evaluation and/or device history review is anticipated but is not complete.Upon completion, a supplemental report will be filed.
 
Event or Problem Description
It was reported while using bd phaseal¿ optima injector n40-o the device broke and leakage occurred.There was no report of patient impact.The following information was provided by the initial reporter: we recently had an incident with injector breaking when technician was adding the chemo.Unfortunately, they did not save the device for us to examine.¿ while a technician was preparing to draw up chemo from the vial, the injector broke off causing chemo to spill in the hood and splash on her gown and floor.This occurred as she was injecting air into the vial to inflate the expansion chamber on the phaseal protector.¿.
 
Additional Manufacturer Narrative
H6: investigation summary: no photos or physical samples that display the reported condition were available for investigation.Product undergoes inspections throughout the manufacturing process to ensure the quality and functionality of the device.As the lot involved in this incident is unknown, a device history review cannot be performed, and additional retained samples cannot be evaluated.Based on the available information we are not able to identify a root cause at this time.
 
Event or Problem Description
It was reported while using bd phaseal¿ optima injector n40-o the device broke and leakage occurred.There was no report of patient impact.The following information was provided by the initial reporter: we recently had an incident with injector breaking when technician was adding the chemo.Unfortunately, they did not save the device for us to examine.¿ while a technician was preparing to draw up chemo from the vial, the injector broke off causing chemo to spill in the hood and splash on her gown and floor.This occurred as she was injecting air into the vial to inflate the expansion chamber on the phaseal protector.¿.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BD PHASEAL¿ OPTIMA INJECTOR N40-O
Common Device Name
INTRAVASCULAR ADMINISTRATION SET
Manufacturer (Section D)
BECTON DICKINSON, S.A.
camino de valdeolivia
s/n
san agustin de guadalix
Manufacturer (Section G)
BECTON DICKINSON, S.A.
camino de valdeolivia
s/n
san agustin de guadalix
Manufacturer Contact
jennifer suh
9450 south state street
sandy, UT 84070
8448235433
MDR Report Key17638812
Report Number3003152976-2023-00357
Device Sequence Number15437908
Product Code ONB
UDI-Device Identifier00382905150579
UDI-Public(01)00382905150579
Combination Product (Y/N)N
Initial Reporter StateWA
Initial Reporter CountryUS
PMA/510(K) Number
K201099
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Other,User Facility
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date (Section B) 09/06/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Other
Device Catalogue Number515057
Device Lot NumberUNKNOWN
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer Not provided
Supplement Date Received by Manufacturer09/06/2023
Initial Report FDA Received Date08/28/2023
Supplement Report FDA Received Date09/21/2023
Was Device Evaluated by Manufacturer? (Y/N) Device Not Returned to Manufacturer
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Patient SexUnknown
-
-